2[1]Eric NP. Cardioversion of atrial fibrillation to sinus rhythm: who,when, how and why? Am J Cardiol. 2000,86 ( 3 ): 326.
3[2]Grant AO. Propafenon: An effeetive agent for the management of supraventricular arrhvthmias. J Cardiolvasc Electrophysiol, 1996, 7(4):353.
4[3]Ganau G,Lenzi T. Intravenous propafenon for converting reeent onset atrial fibrillation in emergency departments: a rancomized placebo controlled multicenter trial. J Emerg Med, 1998, 16 (3): 383.
5[4]Minutiello I. Efficacy of intravenous propafenone in the management of atrial flutter and fibrillation of recent onset. Minerva Cardioangiol, 1994,42(3): 119.
6[1]Wijffels MC,Kirchhof C J, Dorland R, et al. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats.Circulation, 1995; 92:1954～1968
7[2]Petersen P,Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke, 1988; 19: 622～626
8BELLANDI F, SIMONETTI I, LEONCINIM, et al. Long-ter mefficacy and safety of propafenone andsotalol for themaintenance of sinus rhythm after conversion ofrecurrent symptomatic atrial fibrillation[J].Am JCardiol,2001,88(5) :640-646.
9TALAJICM,THIBAULT B. Pilot study and protocol of the canadian trial of a trial fibrillation(CTA F)[J]. N Engl JMed, 2000,34(2) :913-917.
10KREISS Y,SIDI Y,GUR H. Efficacy and safety ofintraveno- us amiodarone in recent onset atrial fibrillation: experience in patients admitted to a general internalmedicine department [J].Posturad Med J,1999,75(2) :278-281.
